Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Number of holders
-
730
-
Total 13F shares, excl. options
-
75,563,046
-
Shares change
-
+4,072,585
-
Total reported value, excl. options
-
$16,555,972,646
-
Value change
-
+$917,790,340
-
Put/Call ratio
-
120%
-
Number of buys
-
445
-
Number of sells
-
-274
-
Price
-
$219.24
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q3 2020
856 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q3 2020.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 730 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75,563,046 shares
of 175,611,455 outstanding shares and own 43% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7,214,520 shares), BAILLIE GIFFORD & CO (6,242,039 shares), BlackRock Inc. (6,138,379 shares), JENNISON ASSOCIATES LLC (5,957,543 shares), Capital World Investors (2,686,127 shares), BANK OF AMERICA CORP /DE/ (2,298,621 shares), ARK Investment Management LLC (2,012,786 shares), JPMORGAN CHASE & CO (1,877,608 shares), STATE STREET CORP (1,503,996 shares), and Discovery Value Fund (1,444,287 shares).
This table shows the top 730 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.